Skip to main content
Clinical Trials/NL-OMON44292
NL-OMON44292CompletedNot Applicable

Innovative MRI techniques to improve treatment stratification of patients with Esophageal cancer: an optimization and pilot study - IMPROVE

Academisch Medisch Centrum0 sites40 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Volunteers:
  • Written informed consent.;Patients:
  • Patients with biopsy proven esophageal cancer (squamous cell carcinoma or adenocarcinoma).
  • Suspected nodal involvement on EUS or CT at diagnosis.
  • WHO-performance score 0-2.
  • Scheduled for surgery.
  • Written informed consent.

Exclusion Criteria

  • Any psychological, familial, sociological or geographical condition potentially hampering adequate informed consent or compliance with the study protocol.
  • Contra-indications for MR scanning, including patients with a pacemaker, cochlear implant or neurostimulator; patients with non-MR compatible metallic implants in their eye, spine, thorax or abdomen; or a non-MR compatible aneurysm clip in their brain; patients with severe claustrophobia.
  • Active inflammatory diseases
  • History of anaphylaxis or other hypersensitivity reactions
  • History of iron overload
  • History of abnormal liver function, or elevated liver enzymes (ALAT, ASAT > 3 times upper limit of normal)
  • Elevated Serum Transferrin Saturation (TSAT) (>50%) or hemoglobin (>10.5mmol/L)
  • Deminished kidney function (eGFR<60)

Investigators

Similar Trials